About me
Dr. Zhong is the Vice President of Biometrics at REGENXBIO. Prior to REGENXBIO, he was a Group Head at Biogen, accountable for Innovative Analytics, Rare Disease Statistics, and others. He has 20 years of industry experience successfully bringing the needed treatments to patients and advancing statistical innovation for drug development. Currently, he is the Rapporteur of the ICH E20 Expert Working Group, leading the development the ICH E20 guideline on Adaptive Clinical Trials. He was an invited expert panelist for the FDA public meeting on Promoting the Use of Complex Innovative Designs in Clinical Trials. He has coauthored book chapters, over 50 manuscripts in peer reviewed medical and statistical journals, and over 100 presentations.
